Treatment of central serous chorioretinopathy with topical NSAIDs

Autor:	Sepehr, Bahadorani, Kyle, Maclean, Kendall, Wannamaker, Edward Rickie, Chu, Nathan, Gresores, Jeong-Hyeon, Sohn, Roberto, Diaz-Rohena, Michael A, Singer
Rok vydání:	2019
Předmět:	NSAIDs subretinal fluid bromfenac CSCR SRF central serous chorioretinopathy CSC nepafenac Original Research
Zdroj:	Clinical Ophthalmology (Auckland, N.Z.)
ISSN:	1177-5467
Popis:	Purpose Central serous chorioretinopathy (CSCR) is a common retinopathy that is often observed until resolution. The purpose of this study is to evaluate the effects of topical nonsteroidal anti-inflammatory drugs (NSAIDs) on timing of CSCR recovery. Methods An IRB-approved retrospective review was conducted on patients that had been diagnosed with a new-onset, symptomatic case of CSCR. Patients were either observed only (13 untreated eyes) or treated with topical bromfenac or nepafenac (14 eyes) over an average of about a 4–5 week follow-up period. Results There was no statistical significance between central macular thickness (CMT) and visual acuity of treatment and control groups at the initial presentation. However, at the follow-up visit, CMT reductions in the treatment group were significantly higher than in the control group (p
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::11058e1e05d943a7d31e5271c542daa7 https://pubmed.ncbi.nlm.nih.gov/31616132 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.